Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tulmimetostat |
| Trade Name | |
| Synonyms | CPI0209|CPI-0209|CPI 0209|DZR123|DZR-123|DZR 123 |
| Drug Descriptions |
Tulmimetostat is a second-generation inhibitor of EZH1 and EZH2, which potentially decreases tumor cell viability and reduces tumor growth (PMID: 38833522). |
| DrugClasses | EZH1 inhibitor 5 EZH2 inhibitor 20 |
| CAS Registry Number | 2567686-02-4 |
| NCIT ID | C167347 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abiraterone + Tulmimetostat | Abiraterone Tulmimetostat | 0 | 1 |
| ARV-766 + Tulmimetostat | ARV-766 Tulmimetostat | 0 | 1 |
| Carboplatin + Tulmimetostat | Carboplatin Tulmimetostat | 0 | 1 |
| Cisplatin + Tulmimetostat | Cisplatin Tulmimetostat | 0 | 0 |
| Darolutamide + Tulmimetostat | Darolutamide Tulmimetostat | 0 | 1 |
| Enzalutamide + Tulmimetostat | Enzalutamide Tulmimetostat | 0 | 1 |
| Irinotecan + Tulmimetostat | Irinotecan Tulmimetostat | 0 | 0 |
| Pembrolizumab + Tulmimetostat | Pembrolizumab Tulmimetostat | 0 | 1 |
| Tulmimetostat | Tulmimetostat | 0 | 2 |